[High dose methotrexate for the therapy of malignant diseases]. 1978

R Catane, and H Catane

UI MeSH Term Description Entries
D008727 Methotrexate An antineoplastic antimetabolite with immunosuppressant properties. It is an inhibitor of TETRAHYDROFOLATE DEHYDROGENASE and prevents the formation of tetrahydrofolate, necessary for synthesis of thymidylate, an essential component of DNA. Amethopterin,Methotrexate Hydrate,Methotrexate Sodium,Methotrexate, (D)-Isomer,Methotrexate, (DL)-Isomer,Methotrexate, Dicesium Salt,Methotrexate, Disodium Salt,Methotrexate, Sodium Salt,Mexate,Dicesium Salt Methotrexate,Hydrate, Methotrexate,Sodium, Methotrexate
D009369 Neoplasms New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms. Benign Neoplasm,Cancer,Malignant Neoplasm,Tumor,Tumors,Benign Neoplasms,Malignancy,Malignant Neoplasms,Neoplasia,Neoplasm,Neoplasms, Benign,Cancers,Malignancies,Neoplasias,Neoplasm, Benign,Neoplasm, Malignant,Neoplasms, Malignant
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

R Catane, and H Catane
February 1982, Gan to kagaku ryoho. Cancer & chemotherapy,
R Catane, and H Catane
February 1977, The Medical journal of Australia,
R Catane, and H Catane
July 1977, Cancer treatment reports,
R Catane, and H Catane
August 1979, Cancer treatment reports,
R Catane, and H Catane
June 1960, Wiener Zeitschrift fur innere Medizin und ihre Grenzgebiete,
R Catane, and H Catane
November 1979, Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke,
R Catane, and H Catane
October 1981, Klinische Wochenschrift,
R Catane, and H Catane
July 1988, Biochemical pharmacology,
Copied contents to your clipboard!